| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30080068 | HIV | ENSG00000134259.6 | protein_coding | NGF | No | No | 4803 | P01138 |
| TVIS20066036 | HPV | ENSG00000134259.6 | protein_coding | NGF | No | No | 4803 | P01138 |
| TVIS44024356 | HTLV-1 | ENSG00000134259.6 | protein_coding | NGF | No | No | 4803 | P01138 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | NGF |
|---|---|
| DrugBank ID | DB12157 |
| Drug Name | Fasinumab |
| Target ID | BE0001094 |
| UniProt ID | P01138 |
| Regulation Type | inhibitor |
| PubMed IDs | 33459118; 33293475 |
| Citations | Kaplon H, Reichert JM: Antibodies to watch in 2021. MAbs. 2021 Jan-Dec;13(1):1860476. doi: 10.1080/19420862.2020.1860476.@@Cao Z, Zhou J, Long Z, Li Y, Sun J, Luo Y, Wang W: Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs. Aging (Albany NY). 2020 Dec 3;13(1):1051-1070. doi: 10.18632/aging.202232. Epub 2020 Dec 3. |
| Groups | Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
